跳至主要内容
临床试验/NCT07532668
NCT07532668已完成不适用

Multicentre Retrospective Cohort Study of Palliative Care Pathways in Patients Who Died From Sarcoma

Centre Leon Berard1 个研究点 分布在 1 个国家目标入组 207 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
207
试验地点
1
主要终点
Palliative pathways of patients who died from sarcoma

研究概览

简要总结

The goal of this observational study is to describe palliative pathways in adult patients who died from their sarcoma.

The main question it aims to answer is:

How patients who died from sarcoma are followed by palliative team.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Oncology follow up in Centre Léon Bérard, or Institut Gustave Roussy, or Institut Curie
  • sarcoma histology confirmed
  • >18 years at diagnosis
  • death between 01/01/2024 ans 31/12/2024
  • death related to sarcoma

排除标准

  • >1 year between last follow up in Centre Léon Bérard, or Institut Gustave Roussy, or Institut Curie and death
  • patient opposed to the collect of data

研究组 & 干预措施

adult patients who died from sarcoma with >1 agressivness near the end of life criteria

adult patients who died from sarcoma with 0-1 agressivness near the end of life criteria

结局指标

主要结局

Palliative pathways of patients who died from sarcoma

时间窗: From date of inclusion until the date of death from any cause, assessed up to 42 months

Palliative pathways will be described using the proportion of patients with each of the following component : * hospitalisation in a palliative care unit, * consultation with palliative care doctor, * mobile palliative care team advice We collect data on the first and last time of each kind of palliative follow up, we collect the number of day between the meeting and death For exemple: palliative care unit: first meeting 200 days before death and last meeting 80 days before death

次要结局

  • Treatment with chemotherapy in the last 14 days of life(From date of inclusion until the date of death from any cause, assessed up to 42 months)
  • More than 1 visit in an emergency unit in the last 30 days of life(From date of inclusion until the date of death from any cause, assessed up to 42 months)
  • Hospitalization in a resuscitation unit in the last 30 days of life(From date of inclusion until the date of death from any cause, assessed up to 42 months)
  • More than 1 hospitalization in the last 30 days of life(From date of inclusion until the date of death from any cause, assessed up to 42 months)
  • Less than 3 days in palliative care unit(From date of inclusion until the date of death from any cause, assessed up to 42 months)
  • New chemotherapy regimen starting in the last 30 days of life(From date of inclusion until the date of death from any cause, assessed up to 42 months)
  • Place of death(At the date of death from any cause, assessed up to 42 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验